Bausch Health Company Insiders

BHC Stock  USD 8.53  0.08  0.95%   
Bausch Health's insiders are aggressively selling. The analysis of insiders' sentiment of trading Bausch Health Companies stock suggests that all insiders are panicking at this time. Bausch Health employs about 20.3 K people. The company is managed by 38 executives with a total tenure of roughly 171 years, averaging almost 4.0 years of service per executive, having 533.42 employees per reported executive.
William Humphries  Chairman
Executive Vice President Company Group Chairman, Dermatology
Joseph Papa  Chairman
Chairman of the Board, Chief Executive Officer

Bausch Health's Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2023-12-05Seana CarsonDisposed 220 @ 7.38View
2023-11-06Seana CarsonDisposed 43 @ 7.61View
2023-09-06Seana CarsonDisposed 6685 @ 8.28View
Monitoring Bausch Health's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

Bausch Health's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Bausch Health's future performance. Based on our forecasts, it is anticipated that Bausch will maintain a workforce of about 20270 employees by May 2024.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Bausch Health's latest congressional trading

Congressional trading in companies like Bausch Health Companies, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Bausch Health by those in governmental positions are based on the same information available to the general public.
2020-08-27Representative Susie LeeDisposed Under $15KVerify

Bausch Health Management Team Effectiveness

The company has Return on Asset of 0.0382 % which means that on every $100 spent on assets, it made $0.0382 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (6.8652) %, meaning that it generated no profit with money invested by stockholders. Bausch Health's management efficiency ratios could be used to measure how well Bausch Health manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 0.61, whereas Return On Tangible Assets are projected to grow to (0.06). At present, Bausch Health's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 2.7 B, whereas Total Assets are forecasted to decline to about 14.9 B.
As of April 23, 2024, Common Stock Shares Outstanding is expected to decline to about 246.3 M. In addition to that, Net Loss is expected to decline to about (212.6 M)

Bausch Health Workforce Comparison

Bausch Health Companies is number one stock in number of employees category among related companies. The total workforce of Health Care industry is currently estimated at about 27,590. Bausch Health totals roughly 20,270 in number of employees claiming about 73% of equities under Health Care industry.

Bausch Health Profit Margins

The company has Net Profit Margin of (0.07) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 0.21 %, which entails that for every 100 dollars of revenue, it generated $0.21 of operating income.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.810.7078
Fairly Up
Very volatile

Bausch Health Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Bausch Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Bausch Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Bausch Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-03-01
0.2308
3
13
 705,990 
 150,726 
2023-12-01
1.0
4
4
 16,676 
 2,288 
2023-09-01
0.8
4
5
 16,269 
 120,063 
2023-06-01
13.0
13
1
 279,562 
 1,929 
2023-03-01
0.5714
12
21
 1,033,324 
 59,123 
2022-12-01
3.0
6
2
 30,883 
 2,025 
2022-09-01
11.0
11
1
 734,670 
 15,389 
2022-06-01
1.7647
30
17
 929,265 
 763,516 
2022-03-01
0.5227
23
44
 1,460,990 
 558,448 
2021-12-01
4.5
9
2
 67,447 
 3,744 
2021-09-01
3.0
12
4
 238,491 
 14,854 
2021-06-01
2.0
22
11
 374,876 
 317,105 
2021-03-01
1.619
34
21
 1,377,114 
 807,889 
2020-12-01
1.0
7
7
 42,000 
 76,832 
2020-09-01
0.8333
5
6
 35,127 
 21,892 
2020-06-01
3.375
27
8
 6,064,443 
 1,172,387 
2020-03-01
1.1667
35
30
 1,320,046 
 254,338 
2019-12-01
4.0
4
1
 4,281 
 3,337 
2019-09-01
1.0
8
8
 118,516 
 65,682 
2019-06-01
2.0
14
7
 111,408 
 129,154 
2019-03-01
1.6923
22
13
 944,388 
 62,273 
2018-12-01
2.3333
7
3
 63,817 
 19,946 
2018-09-01
0.5294
9
17
 209,965 
 234,592 
2018-06-01
6.0
24
4
 283,978 
 105,400 
2018-03-01
3.8333
23
6
 8,656,748 
 7,089,655 
2017-12-01
6.0
6
1
 360,349 
 344,216 
2017-09-01
1.5
6
4
 18,836 
 1,003,273 
2017-06-01
2.3333
14
6
 254,703 
 20,408 
2017-03-01
20.0
20
1
 645,182 
 0.00 
2016-12-01
0.8333
5
6
 9,130,508 
 3,524,643 
2016-09-01
1.1667
7
6
 183,948 
 24,582 
2016-06-01
2.4
24
10
 12,778,244 
 18,240,000 
2016-03-01
0.1429
1
7
 1,096 
 57,408 
2015-12-01
1.5
9
6
 14,227 
 1,314,057 
2015-06-01
1.0357
29
28
 424,183 
 4,843,370 
2015-03-01
0.9167
11
12
 712,680 
 310,412 
2014-12-01
1.3636
15
11
 681,876 
 141,674 
2014-09-01
1.0
4
4
 18,810 
 30,119 

Bausch Health Notable Stakeholders

A Bausch Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Bausch Health often face trade-offs trying to please all of them. Bausch Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Bausch Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
William HumphriesExecutive Vice President Company Group Chairman, DermatologyProfile
Joseph PapaChairman of the Board, Chief Executive OfficerProfile
Thomas AppioExecutive Vice President Company Group Chairman, InternationalProfile
Paul HerendeenChief Financial Officer, Executive Vice PresidentProfile
Joseph GordonPresident and Co-Head Bausch + Lomb/InternationalProfile
Christina AckermannExecutive Vice President, General Counsel and Head of Commercial OperationsProfile
Mark McKennaPresident - Salix PharmaceuticalsProfile
Mirza DautbegovicSenior COOProfile
Sarah KavanaghIndependent DirectorProfile
Richard DeSchutterIndependent DirectorProfile
Robert HaleIndependent DirectorProfile
Richard SchutterIndependent DirectorProfile
Amy WechslerIndependent DirectorProfile
Robert PowerIndependent DirectorProfile
Argeris KarabelasIndependent DirectorProfile
Thomas RossLead Independent DirectorProfile
Andrew EschenbachIndependent DirectorProfile
Elif McDonaldDirector, Investor RelationsProfile
John PaulsonIndependent DirectorProfile
Russel RobertsonIndependent DirectorProfile
John BarresiController, VPProfile
D HaleIndependent DirectorProfile
Jeff HartnessCommercial AccessProfile
Arthur ShannonIR Contact OfficerProfile
Tage MDChief RDProfile
Robert ButzVP AffairsProfile
Brett IcahnIndependent DirectorProfile
Seana CarsonExecutive CounselProfile
Josh CoyleSenior SalixProfile
Graham JacksonSenior OfficerProfile
Sam WillSenior Vice President - Finance, Chief Accounting Officer, ControllerProfile
Thomas VadakethEx CFOProfile
Kathleen FitzpatrickSenior OfficerProfile
Jiny MBASenior MedicalProfile
Donald PearlSenior DermatologicsProfile
Steven MillerIndependent DirectorProfile
Robert SpurrPresident - SalixProfile
Cees HeimanSenior CanadaProfile

About Bausch Health Management Performance

The success or failure of an entity such as Bausch Health Companies often depends on how effective the management is. Bausch Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Bausch management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Bausch management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.06)(0.06)
Return On Capital Employed 0.04  0.04 
Return On Assets(0.02)(0.02)
Return On Equity 0.58  0.61 
The data published in Bausch Health's official financial statements usually reflect Bausch Health's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Bausch Health Companies. For example, before you start analyzing numbers published by Bausch accountants, it's critical to develop an understanding of what Bausch Health's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Bausch Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bausch Health's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Bausch Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Bausch Health Companies. Please utilize our Beneish M Score to check the likelihood of Bausch Health's management manipulating its earnings.

Bausch Health Workforce Analysis

Traditionally, organizations such as Bausch Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Bausch Health within its industry.

Bausch Health Manpower Efficiency

Return on Bausch Health Manpower

Revenue Per Employee432K
Revenue Per Executive230.4M
Net Loss Per Employee30.1K
Net Loss Per Executive16.1M
Working Capital Per Employee63.8K
Working Capital Per Executive34.1M
When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
Note that the Bausch Health Companies information on this page should be used as a complementary analysis to other Bausch Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Bausch Stock analysis

When running Bausch Health's price analysis, check to measure Bausch Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bausch Health is operating at the current time. Most of Bausch Health's value examination focuses on studying past and present price action to predict the probability of Bausch Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bausch Health's price. Additionally, you may evaluate how the addition of Bausch Health to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Is Bausch Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.115
Earnings Share
(1.62)
Revenue Per Share
23.998
Quarterly Revenue Growth
0.098
Return On Assets
0.0382
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.